| Study | Reason for exclusion |
|---|---|
| Abu‐Jawdeh 1996 | No comparison group |
| Ahlgren 1993 | No comparison group |
| Ahlgren 1993a | Published later |
| Anderl 1988 | No comparison group |
| Beecham 1988 | Published later in a peer review journal ‐ Hatch 1991 |
| Belinson 1987 | Tamoxifen in combination with megestrol acetate |
| Bruzzone 1995 | Tamoxifen given in combination with triptorelin |
| Gennatas 1996 | No comparison group |
| Hamerlynck 1985 | No comparison group |
| Hamerlynck 1985 (a) | Duplicate publication ‐ see Hamerlynck 1985 |
| Harvey 1987 | Overlap with patients in Osborne 1988 |
| Hatch 1991 | Probable major overlap of patients with later paper by Markman 1996 |
| Holt 1979 | No comparison group |
| Jaeger 1993 | Published in peer review journal later |
| Jager 1995 | More than one hormonal agent used |
| Jakobsen 1987 | Tamoxifen in combination with medroxyprogesterone acetate |
| Landoni 1983 | Probable overlap with Landoni 1985 |
| Landoni 1985 | No comparison group |
| Lopez 1996 | Tamoxifen in combination with Leuprolide acetate |
| Losa 1993 | 172 patients randomised to three arms of different hormones |
| Markman 1996 | No comparison group |
| Marth 1997 | Excluded as 155 patients treated with tamoxifen, but only 65 evaluable for response. Median survival of 155 patients was 3.8 months (95% CI: 3.3‐ 5.4), 5‐year survival rate was 2%. |
| Millward 1994 | Tamoxifen in combination with etoposide. |
| Milward 1992 | Combination ‐ published in several sources |
| Osborne 1987(a) | Duplication of Osborne 1988 |
| Osborne 1987(b) | Duplication of Osborne 1988 |
| Osborne 1988 | No comparison group |
| Schwartz 1989 | RCT of chemotherapy (cisplatin/doxorubicin) with or without tamoxifen. No survival differences between the groups (49 with tamoxifen, 51 without). Hormone receptors did not correlate with outcome. |
| Schwarz 1980 | No comparison group. There was evidence of correlation between the level of oestrogen receptors and stable disease. |
| Shirey 1985 | No comparison group |
| Slevin 1986 | No comparison group |
| Trippa 1993 | Tamoxifen in combination with beta interferon |
| van der Vange 1995 | Multiple different hormonal therapies |
| van der Velden 1995 | No comparison group |
| Weiner 1987 | No comparison group |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.